Omidele Olamide, Elkun Yuval, Connors Christopher, Eraky Ahmed, Mehrazin Reza
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Cancers (Basel). 2025 Jan 21;17(3):334. doi: 10.3390/cancers17030334.
The da Vinci single-port (SP) platform is emerging as the latest innovation in minimally invasive surgery and its utilization in treating urologic malignancies continues to expand.
A search was conducted in PubMed, MEDLINE, and ScienceDirect. The final set includes 40 academic articles.
Research on single-port surgery for genitourinary cancer is still an emerging topic. We divided the topic into the following categories: radical prostatectomy, radical cystectomy, nephrectomy, and nephroureterectomy.
The single-port platform provides urologists with another tool to tackle more complex surgical cases and pathologies with the added improvements of decreased length of stay and increased pain tolerance for patients.
达芬奇单孔(SP)平台正成为微创手术的最新创新技术,其在治疗泌尿生殖系统恶性肿瘤中的应用不断扩大。
在PubMed、MEDLINE和ScienceDirect数据库中进行了检索。最终纳入40篇学术文章。
泌尿生殖系统癌症单孔手术的研究仍是一个新兴话题。我们将该话题分为以下几类:根治性前列腺切除术、根治性膀胱切除术、肾切除术和肾输尿管切除术。
单孔平台为泌尿外科医生提供了另一种工具,可用于处理更复杂的手术病例和病理情况,同时还能进一步缩短患者住院时间,提高患者的疼痛耐受性。